Tag: PMA

April 19, 2018

Sientra Receives FDA Approval of PMA Supplement

Sientra (NASDAQ:SIEN) a medical aesthetics company, today announced U.S. Food and Drug Administration (FDA) approval of the Company’s PMA supplement...
April 3, 2018

Abiomed Receives FDA Approval for Impella CP with SmartAssist and Optical Sensor

Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today that it has received U.S. Food...
March 14, 2018

Sientra Reports Fourth Quarter and Full Year 2017 Financial Results

Sientra (NASDAQ:SIEN) a medical aesthetics company, today announced its financial results for the fourth quarter and full year ended December...
February 14, 2018

Abiomed Receives Approval for Expanded FDA Indication

Abiomed (Nasdaq:ABMD), a leading provider of breakthrough heart support and recovery technologies, today announced that it has received an expanded...
February 13, 2018

Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock

Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today that it has received an expanded...
January 31, 2018

Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility

Sientra, (NASDAQ:SIEN) a medical aesthetics company, today provided an update on its pre-market approval (PMA) supplement for a site-change to...
January 22, 2018

United Health Products Issues FDA Update

United Health Products (OTCPK:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today...